Related Experiment Video
Updated: Jan 22, 2026

Preparation and Characterization of Novel HDL-mimicking Nanoparticles for Nerve Growth Factor Encapsulation
Published on: May 22, 2017
HDL-C and non-HDL-C levels are associated with anthropometric and biochemical parameters
Sandra Maria Barbalho1,2, Ricardo José Tofano1, Marcela Bueno de Oliveira1
1Universidade de Marília - UNIMAR, Faculdade de Medicina, Departamento de Bioquímica e Farmacologia, Marília, SP, Brasil.
Insights
High-density lipoprotein cholesterol (HDL-c) and non-high-density lipoprotein cholesterol (non-HDL-c) levels are linked to cardiovascular disease risk factors like obesity and insulin resistance. Further trials are needed to explore non-HDL-c as a therapeutic target.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Biochemistry
Background:
- Dyslipidemias are established risk factors for atherosclerosis and cardiovascular diseases (CVD).
- Non-high-density lipoprotein cholesterol (non-HDL-c) is increasingly recognized for its role in predicting CVD risk and atheroma plaque progression.
- HDL-c and non-HDL-c are key lipid parameters influencing cardiovascular health.
Purpose of the Study:
- To investigate the associations between HDL-c and non-HDL-c levels with anthropometric and biochemical markers.
- To evaluate the relationship between HDL-c and non-HDL-c with Castelli risk indexes I and II.
- To understand the clinical significance of altered HDL-c and non-HDL-c in relation to metabolic syndrome.
Main Methods:
- A study involving 300 randomly selected individuals, categorized by normal or altered non-HDL-c values.
- Analysis of associations between lipid profiles (HDL-c, non-HDL-c, TC, TG, LDL-c) and anthropometric measures (WC, BMI).
- Assessment of correlations with glycemia, Castelli Indexes (CI-I, CI-II), and the prevalence of metabolic syndrome (MS).
Main Results:
- Significant differences in glycemia, TC, TG, LDL-c, CI-I, CI-II, WC, and BMI were observed between groups with normal and altered HDL-c and non-HDL-c.
- Higher TC and WC values were noted in patients with abnormal non-HDL-c compared to those with abnormal HDL-c.
- A significant difference in the occurrence of MS was found in individuals with altered HDL-c and non-HDL-c levels.
Conclusions:
- Both HDL-c and non-HDL-c are significantly associated with insulin resistance, dyslipidemia, atherogenic indices, and obesity.
- The findings highlight the clinical relevance of monitoring both HDL-c and non-HDL-c for cardiovascular risk assessment.
- Further randomized clinical trials are warranted to explore the potential of non-HDL-c as a primary therapeutic target for CVD prevention.
Background:
Dyslipidemias are associated with atherosclerosis and cardiovascular diseases. Recently, non-high-density lipoprotein cholesterol (non-HDL-c) has emerged as a new target for assessment and prediction of risk of cardiovascular disease (CVD) and is closely associated with atheroma plaque progression.
Objectives:
To evaluate associations between HDL-c and non-HDL-c levels and anthropometric and biochemical parameters and with the Castelli risk indexes I and II.
Methods:
300 randomly selected people were subdivided into two groups: patients with normal values for non-HDL-c and patients with altered values for non-HDL-c. These parameters were analyzed for associations with glycemia, total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL-c), Castelli Index I (CI-I), Castelli Index II (CI-II), waist circumference (WC), body mass index (BMI) and presence of metabolic syndrome (MS).
Results:
Glycemia, TC, TG, LDL-c, CI-I, CI-II, WC and BMI were all significantly different between subjects with normal and altered values of HDL-c and non-HDL-c. TC and WC both exhibited significantly higher values among patients with abnormal non-HDL-c when compared to patients with abnormal HDL-c. A significant difference was observed in occurrence of MS among patients with altered values of HDL-c and non-HDL-c.
Conclusions:
Our results show that both HDL-c and non-HDL-c are associated with insulin resistance, dyslipidemia, atherogenic indices, and obesity. There is therefore a need for randomized clinical intervention trials examining the potential role of non-HDL-c as a possible primary therapeutic target.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
11:23Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
Related Concept Videos
Wave Parameters
High-Level and Low-Level Awareness
Leveling Effect
Levels of Organization
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
Fermi Level
At absolute zero temperature, electrons fill all energy states up to the Fermi level, leaving upper states empty. As the temperature rises,...
Distributions to Estimate Population Parameter